US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyell Immunopharma, Inc.

11.02

-0.7900-6.69%

Post-market: 11.020.00000.00%16:33 EDT

Volume:19.79K

Turnover:222.92K

Market Cap:170.34M

PE:-0.45

High:11.67

Open:11.57

Low:11.02

Close:11.81

Loading ...

Overview Company News Filings

Lyell Immunopharma Announces 1-for-20 Reverse Stock Split Effective May 30, 2025

Lyell Immunopharma Stockholders Approve Key Proposals

Lyell Immunopharma Inc. Conducted Annual Stockholders Meeting

Morgan Stanley Keeps Their Hold Rating on Lyell Immunopharma (LYEL)

Lyell Immunopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Lyell Immunopharma Q1 EPS $(0.18) Beats $(0.20) Estimate, Sales $7.00K Up From $3.00K YoY

BRIEF-Lyell Immunopharma Q1 Net Income USD -52.195 Million

Lyell Immunopharma Inc. Reports Decreased Net Loss of $52.2 Million in Q1 2025, Driven by Absence of Prior Year Impairment Expenses

Lyell Immunopharma Inc expected to post a loss of 18 cents a share - Earnings Preview

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

Cautious Hold Rating on Lyell Immunopharma Amid Promising Developments and Competitive Challenges

Lyell Immunopharma Says its Relapsed Large B-Cell Lymphoma Therapy Receives US FDA's REMAT Designation

MT Newswires Live

Director’s Bold Move: Major Stock Purchase in Lyell Immunopharma!

Lyell Immunopharma to Cut Jobs, Close West Hills Plant

BRIEF-Lyell Immunopharma Inc - To Close West Hills Manufacturing Facility - SEC Filing

Investor Interest in Lyell Immunopharma Stock (LYEL) Surges on Positive Analyst Report

Favourable Signals For Lyell Immunopharma: Numerous Insiders Acquired Stock

Simply Wall St.

Lyell Immunopharma Price Target Maintained With a $1.00/Share by HC Wainwright & Co.

Lyell Immunopharma’s Global Expansion Strategy: Navigating Risks and Challenges

Lyell Immunopharma Q4 Sales $11.00K Down From $13.00K YoY

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LYEL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LYEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYEL\",,,,,undefined,":{"symbol":"LYEL","market":"US","secType":"STK","nameCN":"Lyell Immunopharma, Inc.","latestPrice":11.02,"timestamp":1754078400000,"preClose":11.81,"halted":0,"volume":19786,"hourTrading":{"tag":"盘后","latestPrice":11.02,"preClose":11.02,"latestTime":"16:33 EDT","volume":154,"amount":1697.3,"timestamp":1754080428763},"delay":0,"floatShares":10620934,"shares":15457400,"eps":-24.625135,"marketStatus":"Market Closed","change":-0.79,"latestTime":"08-01 16:00:00 EDT","open":11.57,"high":11.665,"low":11.02,"amount":222915.439,"amplitude":0.054615,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-24.625135,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":11.81,"preHourTrading":{"tag":"盘前","latestPrice":11.81,"preClose":11.81,"latestTime":"08:00 EDT","volume":1,"amount":11.81,"timestamp":1754049600789},"postHourTrading":{"tag":"盘后","latestPrice":11.02,"preClose":11.02,"latestTime":"16:33 EDT","volume":154,"amount":1697.3,"timestamp":1754080428763},"volumeRatio":0.10852574564381262,"impliedVol":1.2021,"impliedVolPercentile":0.4578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYEL\",,,,,undefined,":{"symbol":"LYEL","floatShares":10620934,"roa":"-24.40%","roe":"-71.20%","lyrEps":-26.234817,"volumeRatio":0.10852574564381262,"shares":15457400,"dividePrice":0,"high":11.665,"amplitude":0.054615,"preClose":11.81,"low":11.02,"week52Low":7.65,"pbRate":"0.51","psRate":"2620.62","week52High":32.4,"institutionHeld":0,"latestPrice":11.02,"eps":-24.625135,"divideRate":0,"volume":19786,"delay":0,"ttmEps":-24.625135,"open":11.57,"prevYearClose":12.8,"prevWeekClose":12.42,"prevMonthClose":11.81,"prevQuarterClose":8.84,"fiveDayClose":12.42,"twentyDayClose":9.69,"sixtyDayClose":8.314},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LYEL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2539064074","title":"Lyell Immunopharma Announces 1-for-20 Reverse Stock Split Effective May 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2539064074","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539064074?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:01","pubTimestamp":1748462477,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. announced a reverse stock split at a ratio of 1-for-20, effective May 30, 2025. This move will consolidate every 20 shares of the company's common stock into one share, without altering the par value per share. The company's stock will trade on a split-adjusted basis on the Nasdaq Global Select Market starting June 2, 2025, under the new CUSIP number 55083R203. Following the split, the number of outstanding shares will reduce from approximately 296 million to around 14.8 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL6jBWpQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","LYEL","BK4505"],"gpt_icon":0},{"id":"2537951632","title":"Lyell Immunopharma Stockholders Approve Key Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2537951632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537951632?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:39","pubTimestamp":1747859966,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma ( ($LYEL) ) has shared an update. On May 15, 2025, Lyell Immunopharma held its annual meeting of stockholders virtually, with 71...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-stockholders-approve-key-proposals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-stockholders-approve-key-proposals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LYEL","BK4505","BK4539"],"gpt_icon":0},{"id":"2537959885","title":"Lyell Immunopharma Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2537959885","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537959885?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:06","pubTimestamp":1747858005,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. held its annual meeting of stockholders on May 15, 2025. Stockholders approved the election of Catherine Friedman as a Class I director. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. A proposal to effect a reverse stock split of common stock at a ratio between 1-for-10 and 1-for-25, at the discretion of the Board of Directors, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL5Y29r7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","BK4139","BK4505","BK4539"],"gpt_icon":0},{"id":"2536268253","title":"Morgan Stanley Keeps Their Hold Rating on Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536268253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536268253?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:47","pubTimestamp":1747658865,"startTime":"0","endTime":"0","summary":"In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Lyell Immunopharma (LYEL – Research Report). The company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-lyell-immunopharma-lyel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-lyell-immunopharma-lyel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LYEL"],"gpt_icon":0},{"id":"2535339036","title":"Lyell Immunopharma Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535339036","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535339036?lang=en_us&edition=fundamental","pubTime":"2025-05-14 06:29","pubTimestamp":1747175383,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc reports results for the quarter ended March 31 - Earnings SummaryLyell Immunopharma Inc LYEL.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL36K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0},{"id":"2535809150","title":"Lyell Immunopharma Q1 EPS $(0.18) Beats $(0.20) Estimate, Sales $7.00K Up From $3.00K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2535809150","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535809150?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:59","pubTimestamp":1747169990,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 25 percent increase over losses of $(0.24) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45392536/lyell-immunopharma-q1-eps-0-18-beats-0-20-estimate-sales-7-00k-up-from-3-00k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0},{"id":"2535855084","title":"BRIEF-Lyell Immunopharma Q1 Net Income USD -52.195 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535855084","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535855084?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:05","pubTimestamp":1747166746,"startTime":"0","endTime":"0","summary":"BRIEF-Lyell Immunopharma Q1 Net Income USD -52.195 Million\n\n\nMay 13 (Reuters) - Lyell Immunopharma Q1 revenue USD 7 thousand.\n\nQ1 operating expenses USD 57.374 million\nQ1 adjusted net income USD -46.296 million\nQ1 operating income USD -57.367 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLXD3E084:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","BK4539","BK4505","BK4139"],"gpt_icon":0},{"id":"2535848160","title":"Lyell Immunopharma Inc. Reports Decreased Net Loss of $52.2 Million in Q1 2025, Driven by Absence of Prior Year Impairment Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2535848160","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535848160?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:05","pubTimestamp":1747166714,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. Reports Decreased Net Loss of $52.2 Million in Q1 2025, Driven by Absence of Prior Year Impairment Expenses. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on May 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDLblVDxy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4139","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","LYEL","IE00BGHQF748.EUR","BK4585","LU2095319765.USD","NDAQ","BK4539","BK4588","BK4505","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2532843881","title":"Lyell Immunopharma Inc  expected to post a loss of 18 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532843881","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532843881?lang=en_us&edition=fundamental","pubTime":"2025-05-02 20:11","pubTimestamp":1746187866,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc  expected to post a loss of18cents a share - Earnings Preview Lyell Immunopharma Inc LYEL.OQ LYEL.O is expected to show a fall in quarterly revenue when it reports  results on M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA1JQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0},{"id":"2532077044","title":"Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532077044","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532077044?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:00","pubTimestamp":1746104400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., May 01, 2025  -- Lyell Immunopharma, Inc. , a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, today announced that an abstract highlighting new clinical data from the Phase 1/2 trial of LYL314  in large B-cell lymphoma will be presented as an oral presentation at the International Conference on Malignant Lymphoma  2025 taking place in Lugano, Switzerland June 17-21, 2025.LYL314 is a dual-targeting CD19/CD20 chimeric antigen receptor  T-cell product candidate in development for patients with aggressive large B-cell lymphoma. LYL314 has received Regenerative Medicine Advanced Therapy and Fast Track designations from the U.S. Food and Drug Administration for the treatment of patients with relapsed and/or refractory diffuse large B-cell lymphoma in the 3rd or later line setting.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lyell-immunopharma-announces-oral-presentation-130000007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4230","LYEL","BK4505","CAR","BK4539","BK4022","BK4139"],"gpt_icon":0},{"id":"2527939712","title":"Cautious Hold Rating on Lyell Immunopharma Amid Promising Developments and Competitive Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2527939712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527939712?lang=en_us&edition=fundamental","pubTime":"2025-04-16 18:16","pubTimestamp":1744798603,"startTime":"0","endTime":"0","summary":"Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Hold rating on Lyell Immunopharma (LYEL – Research Report) and keeping the price target a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-on-lyell-immunopharma-amid-promising-developments-and-competitive-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-on-lyell-immunopharma-amid-promising-developments-and-competitive-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LYEL"],"gpt_icon":0},{"id":"2527446313","title":"Lyell Immunopharma Says its Relapsed Large B-Cell Lymphoma Therapy Receives US FDA's REMAT Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2527446313","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527446313?lang=en_us&edition=fundamental","pubTime":"2025-04-15 22:46","pubTimestamp":1744728362,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma  said Tuesday its therapy candidate for treating relapsed or refractory large B-cell lymphoma, LYL314, has received the US Food and Drug Administration's Regenerative Medicine Advanced Therapy designation.The RMAT designation provides all the benefits of Fast Track and Breakthrough Therapy designations, Lyell said. The FDA's designation drew on initial findings from an ongoing phase 1/2 trial, the company said.Two pivotal trials are expected to start in mid-2025 and early 2026, the company added.Shares of the company were up 3% in recent Tuesday trading.Price: 0.46, Change: +0.01, Percent Change: +3.13","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LYEL","BK4505","BK4539","BK4139"],"gpt_icon":0},{"id":"2524647666","title":"Director’s Bold Move: Major Stock Purchase in Lyell Immunopharma!","url":"https://stock-news.laohu8.com/highlight/detail?id=2524647666","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524647666?lang=en_us&edition=fundamental","pubTime":"2025-04-03 10:04","pubTimestamp":1743645850,"startTime":"0","endTime":"0","summary":"New insider activity at Lyell Immunopharma ( ($LYEL) ) has taken place on April 3, 2025. Director Otis W. Brawley has made a significant investment...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-stock-purchase-in-lyell-immunopharma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-stock-purchase-in-lyell-immunopharma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4539","BK4139","LYEL"],"gpt_icon":0},{"id":"2524122659","title":"Lyell Immunopharma to Cut Jobs, Close West Hills Plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2524122659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524122659?lang=en_us&edition=fundamental","pubTime":"2025-04-02 05:40","pubTimestamp":1743543600,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma is cutting about 73 jobs as a result of its decision to shutter a manufacturing facility it acquired as part of a deal to buy the clinical-stage company ImmPACT Bio last year.The biotechnology company on Tuesday said that it expects to book expenses of $3 million to $4 million in the second and third quarters of this year.The company said closure of the West Hills, Calif., facility comes as it expects its center in Bothell, Wash., to have the capacity to provide drugs for the continuing and planned pivotal trials of IMPT-314, and through a potential commercial launch of the treatment.The company also said that Chief Business Officer Matthew Lang has resigned and will leave his position April 13. Lang will remain an adviser to the company until Sept. 30.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","LYEL","BK4505"],"gpt_icon":0},{"id":"2524529124","title":"BRIEF-Lyell Immunopharma Inc - To Close West Hills Manufacturing Facility - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524529124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524529124?lang=en_us&edition=fundamental","pubTime":"2025-04-02 05:05","pubTimestamp":1743541536,"startTime":"0","endTime":"0","summary":"BRIEF-Lyell Immunopharma Inc - To Close West Hills Manufacturing Facility - SEC FilingApril 1  - Lyell Immunopharma Inc LYEL.O:LYELL IMMUNOPHARMA INC - TO CLOSE WEST HILLS MANUFACTURING FACILITY - SEC FILINGLYELL IMMUNOPHARMA INC - TO REDUCE WORKFORCE BY 73 EMPLOYEES IN WEST HILLS - SEC FILINGLYELL IMMUNOPHARMA INC - EXPECTS $3M-$4M EXPENSES FROM WORKFORCE REDUCTION - SEC FILINGLYELL IMMUNOPHARMA INC - LYFE MANUFACTURING CENTER PRODUCING IMPT-314 FOR PHASE 1/2 TRIAL - SEC FILINGLYELL IMMUNOPHARMA INC - LYFE MANUFACTURING CENTER EXPECTED TO MEET DRUG SUPPLY NEEDS - SEC FILINGLYELL IMMUNOPHARMA INC: REITERATES ITS FINANCIAL GUIDANCESource text: [ID:n0001193125-25-070521]Further company coverage: LYEL.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF119:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","LYEL","BK4505"],"gpt_icon":0},{"id":"2521722849","title":"Investor Interest in Lyell Immunopharma Stock (LYEL) Surges on Positive Analyst Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2521722849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521722849?lang=en_us&edition=fundamental","pubTime":"2025-03-23 07:28","pubTimestamp":1742686103,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma’s ($LYEL) jumped over 8% on Friday as investors’ interest surged. Despite posting unimpressive Q4 results a week earlier, the tu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/investor-interest-in-lyell-immunopharma-stock-lyel-surges-on-positive-analyst-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/investor-interest-in-lyell-immunopharma-stock-lyel-surges-on-positive-analyst-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0},{"id":"2520456774","title":"Favourable Signals For Lyell Immunopharma: Numerous Insiders Acquired Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2520456774","media":"Simply Wall St.","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520456774?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:01","pubTimestamp":1742468492,"startTime":"0","endTime":"0","summary":"When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in Lyell Immunopharma, Inc.'s  instance, it's good news for shareholders.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.Lyell Immunopharma Insider Transactions Over The Last Year. The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. While the overall levels of insider ownership are below what we'd like to see, the history of transactions imply that Lyell Immunopharma insiders are reasonably well aligned, and optimistic for the future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks faci","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/favourable-signals-lyell-immunopharma-numerous-110132684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LYEL","BK4139","BK4505","BK4539"],"gpt_icon":0},{"id":"2519882476","title":"Lyell Immunopharma Price Target Maintained With a $1.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2519882476","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519882476?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:49","pubTimestamp":1741862940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LYEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2025 06:49 ET (10:49 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0},{"id":"2519070154","title":"Lyell Immunopharma’s Global Expansion Strategy: Navigating Risks and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2519070154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519070154?lang=en_us&edition=fundamental","pubTime":"2025-03-13 14:01","pubTimestamp":1741845684,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc. (LYEL) has disclosed a new risk, in the International Operations category. Lyell Immunopharma, Inc.’s strategic initiative...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharmas-global-expansion-strategy-navigating-risks-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharmas-global-expansion-strategy-navigating-risks-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4600","BK4595","BK4023","BK4139","STRK","BK4539","BK4585","LYEL","BK4596","BK4516","BK4505","BK4588"],"gpt_icon":0},{"id":"2518477165","title":"Lyell Immunopharma Q4 Sales $11.00K Down From $13.00K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2518477165","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518477165?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:09","pubTimestamp":1741723782,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma (NASDAQ:LYEL) reported $11.00 thousand in sales this quarter. This is a 15.38 percent decrease over sales of $13.00 thousand the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44262354/lyell-immunopharma-q4-sales-11-00k-down-from-13-00k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Lyell Immunopharma Q4 Sales $11.00K Down From $13.00K YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LYEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-02","symbol":"LYEL","defaultRemindTime":1748871000000,"type":"split","dateTimestamp":1748836800000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2025-05-13","symbol":"LYEL","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2021-08-12","symbol":"LYEL","fiscalQuarterEnding":"2021/06","expectedEps":-1.54,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LYEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LYEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.5,"sell":0.5,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":2,"updateTime":1730347200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LYEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LYEL","date":"2025-08-01","current":-0.523591,"percent":0.911794,"low":-22.356321,"twenty":-7.306207,"median":-3.009843,"eighty":-1.505683,"high":-0.344317,"avg":-4.904302,"sd":4.83952,"marketCap":175152551},"quantilePoints":[{"date":"2021-06-18","current":-16.694562,"twenty":-17.926867,"median":-17.666247,"eighty":-17.121201,"marketCap":3844340254},{"date":"2021-06-25","current":-16.478151,"twenty":-17.614123,"median":-17.106773,"eighty":-16.61212,"marketCap":3794506214},{"date":"2021-07-02","current":-16.519372,"twenty":-17.263414,"median":-16.936736,"eighty":-16.511128,"marketCap":3803998412},{"date":"2021-07-09","current":-16.364793,"twenty":-17.143872,"median":-16.715173,"eighty":-16.410136,"marketCap":3768402669},{"date":"2021-07-16","current":-17.426237,"twenty":-17.174788,"median":-16.735783,"eighty":-16.482273,"marketCap":4012826772},{"date":"2021-07-23","current":-14.870526,"twenty":-17.174788,"median":-16.725478,"eighty":-16.253496,"marketCap":3424310486},{"date":"2021-07-30","current":-14.942663,"twenty":-17.143872,"median":-16.560593,"eighty":-15.769148,"marketCap":3440921833},{"date":"2021-08-06","current":-16.117466,"twenty":-17.090285,"median":-16.509067,"eighty":-15.769148,"marketCap":3711449480},{"date":"2021-08-13","current":-18.445521,"twenty":-17.143872,"median":-16.498762,"eighty":-15.358997,"marketCap":3545487430},{"date":"2021-08-20","current":-18.856529,"twenty":-17.417993,"median":-16.627578,"eighty":-15.57953,"marketCap":3624488838},{"date":"2021-08-27","current":-20.214099,"twenty":-17.926867,"median":-16.735783,"eighty":-15.769148,"marketCap":3885432883},{"date":"2021-09-03","current":-20.525469,"twenty":-18.490358,"median":-16.802768,"eighty":-15.903116,"marketCap":3945282434},{"date":"2021-09-10","current":-22.356321,"twenty":-19.232663,"median":-17.003721,"eighty":-15.991741,"marketCap":4297197797},{"date":"2021-09-17","current":-14.709089,"twenty":-19.232663,"median":-16.952194,"eighty":-15.876323,"marketCap":2827292812},{"date":"2021-09-24","current":-15.294463,"twenty":-19.005986,"median":-16.777005,"eighty":-15.276839,"marketCap":2939809969},{"date":"2021-10-01","current":-16.552396,"twenty":-18.789273,"median":-16.78731,"eighty":-15.333339,"marketCap":3181602157},{"date":"2021-10-08","current":-16.116478,"twenty":-18.505304,"median":-16.725478,"eighty":-15.276839,"marketCap":3097812785},{"date":"2021-10-15","current":-16.539941,"twenty":-18.44303,"median":-16.694562,"eighty":-15.276839,"marketCap":3179208175},{"date":"2021-10-22","current":-17.175134,"twenty":-18.41563,"median":-16.725478,"eighty":-15.333339,"marketCap":3301301260},{"date":"2021-10-29","current":-17.361956,"twenty":-18.41563,"median":-16.78731,"eighty":-15.492314,"marketCap":3337210991},{"date":"2021-11-05","current":-17.212499,"twenty":-18.44303,"median":-16.889297,"eighty":-15.548067,"marketCap":3308483206},{"date":"2021-11-12","current":-13.33676,"twenty":-18.41563,"median":-16.78731,"eighty":-15.276839,"marketCap":2738970350},{"date":"2021-11-19","current":-12.657627,"twenty":-18.330937,"median":-16.725478,"eighty":-15.027931,"marketCap":2599496882},{"date":"2021-11-26","current":-10.90125,"twenty":-18.271154,"median":-16.627578,"eighty":-14.942663,"marketCap":2238789637},{"date":"2021-12-03","current":-10.409464,"twenty":-18.134152,"median":-16.539941,"eighty":-14.709089,"marketCap":2137791608},{"date":"2021-12-10","current":-10.948086,"twenty":-18.109242,"median":-16.493609,"eighty":-14.3479,"marketCap":2248408496},{"date":"2021-12-17","current":-9.765459,"twenty":-18.071878,"median":-16.415393,"eighty":-13.737616,"marketCap":2005532284},{"date":"2021-12-23","current":-9.613239,"twenty":-18.012095,"median":-16.364793,"eighty":-12.985484,"marketCap":1974270990},{"date":"2021-12-31","current":-9.062908,"twenty":-17.940923,"median":-16.245376,"eighty":-12.198627,"marketCap":1861249386},{"date":"2022-01-07","current":-7.470459,"twenty":-17.926867,"median":-16.141388,"eighty":-11.395378,"marketCap":1534208150},{"date":"2022-01-14","current":-7.072347,"twenty":-17.903382,"median":-16.080903,"eighty":-10.997265,"marketCap":1452447841},{"date":"2022-01-21","current":-6.123903,"twenty":-17.830255,"median":-16.014551,"eighty":-10.929352,"marketCap":1257665929},{"date":"2022-01-28","current":-6.147321,"twenty":-17.680798,"median":-15.983497,"eighty":-10.514847,"marketCap":1262475359},{"date":"2022-02-04","current":-6.627398,"twenty":-17.596106,"median":-15.610877,"eighty":-9.704571,"marketCap":1361068673},{"date":"2022-02-11","current":-7.072347,"twenty":-17.556251,"median":-15.294463,"eighty":-9.011387,"marketCap":1452447841},{"date":"2022-02-18","current":-7.013801,"twenty":-17.470271,"median":-15.182102,"eighty":-8.728025,"marketCap":1440424267},{"date":"2022-02-25","current":-8.102755,"twenty":-17.425434,"median":-15.057823,"eighty":-8.163643,"marketCap":1664062759},{"date":"2022-03-04","current":-7.634387,"twenty":-17.416789,"median":-14.958184,"eighty":-7.964586,"marketCap":1567874160},{"date":"2022-03-11","current":-7.669515,"twenty":-17.388159,"median":-14.860221,"eighty":-7.915408,"marketCap":1575088305},{"date":"2022-03-18","current":-7.013801,"twenty":-17.351992,"median":-14.709089,"eighty":-7.723377,"marketCap":1440424267},{"date":"2022-03-25","current":-5.971683,"twenty":-17.3221,"median":-14.403329,"eighty":-7.58755,"marketCap":1226404634},{"date":"2022-04-01","current":-5.20082,"twenty":-17.2947,"median":-14.061441,"eighty":-7.470459,"marketCap":1301343937},{"date":"2022-04-08","current":-5.288147,"twenty":-17.257336,"median":-13.830028,"eighty":-7.346342,"marketCap":1323194861},{"date":"2022-04-14","current":-5.229929,"twenty":-17.211964,"median":-13.518506,"eighty":-7.16602,"marketCap":1308627578},{"date":"2022-04-22","current":-5.045571,"twenty":-17.203643,"median":-12.938648,"eighty":-7.018485,"marketCap":1262497849},{"date":"2022-04-29","current":-4.97765,"twenty":-17.178155,"median":-12.487844,"eighty":-6.955255,"marketCap":1245502686},{"date":"2022-05-06","current":-5.152305,"twenty":-17.173828,"median":-11.627219,"eighty":-6.641449,"marketCap":1289204534},{"date":"2022-05-13","current":-3.729604,"twenty":-17.156239,"median":-11.381327,"eighty":-6.524357,"marketCap":982079216},{"date":"2022-05-20","current":-3.841772,"twenty":-17.098529,"median":-11.135433,"eighty":-6.360429,"marketCap":1011615433},{"date":"2022-05-27","current":-4.056762,"twenty":-17.063491,"median":-10.953941,"eighty":-6.039597,"marketCap":1068226516},{"date":"2022-06-03","current":-4.711078,"twenty":-17.055247,"median":-10.924668,"eighty":-5.971683,"marketCap":1240521115},{"date":"2022-06-10","current":-4.767162,"twenty":-16.952194,"median":-10.74903,"eighty":-5.501614,"marketCap":1255289224},{"date":"2022-06-17","current":-5.103668,"twenty":-16.826401,"median":-10.444591,"eighty":-5.278444,"marketCap":1343897875},{"date":"2022-06-24","current":-6.225353,"twenty":-16.81986,"median":-9.993788,"eighty":-5.286206,"marketCap":1639260045},{"date":"2022-07-01","current":-5.599079,"twenty":-16.793493,"median":-9.191709,"eighty":-5.303672,"marketCap":1474349500},{"date":"2022-07-08","current":-6.281438,"twenty":-16.774943,"median":-9.016071,"eighty":-5.331041,"marketCap":1654028154},{"date":"2022-07-15","current":-5.514953,"twenty":-16.748149,"median":-8.822869,"eighty":-5.314216,"marketCap":1452197337},{"date":"2022-07-22","current":-5.3467,"twenty":-16.723417,"median":-8.664796,"eighty":-5.314216,"marketCap":1407893012},{"date":"2022-07-29","current":-5.206489,"twenty":-16.702806,"median":-8.301811,"eighty":-5.299791,"marketCap":1370972740},{"date":"2022-08-05","current":-7.600529,"twenty":-16.614181,"median":-8.044209,"eighty":-5.299791,"marketCap":1801690265},{"date":"2022-08-12","current":-7.642348,"twenty":-16.555675,"median":-7.991734,"eighty":-5.314216,"marketCap":1811603279},{"date":"2022-08-19","current":-7.360072,"twenty":-16.544923,"median":-7.950535,"eighty":-5.335483,"marketCap":1744690435},{"date":"2022-08-26","current":-6.575974,"twenty":-16.5276,"median":-7.950535,"eighty":-5.3467,"marketCap":1558821426},{"date":"2022-09-02","current":-7.192798,"twenty":-16.507006,"median":-7.89199,"eighty":-5.375608,"marketCap":1705038380},{"date":"2022-09-09","current":-7.935078,"twenty":-16.49464,"median":-7.88028,"eighty":-5.416736,"marketCap":1880994376},{"date":"2022-09-16","current":-7.516892,"twenty":-16.484334,"median":-7.897852,"eighty":-5.449521,"marketCap":1781864237},{"date":"2022-09-23","current":-6.670066,"twenty":-16.453048,"median":-7.861895,"eighty":-5.45326,"marketCap":1581125707},{"date":"2022-09-30","current":-7.663257,"twenty":-16.400447,"median":-7.848297,"eighty":-5.462607,"marketCap":1816559786},{"date":"2022-10-07","current":-7.391436,"twenty":-16.372735,"median":-7.851441,"eighty":-5.468216,"marketCap":1752125196},{"date":"2022-10-14","current":-6.83734,"twenty":-16.35016,"median":-7.81485,"eighty":-5.468216,"marketCap":1620777762},{"date":"2022-10-21","current":-6.847795,"twenty":-16.313264,"median":-7.751479,"eighty":-5.477563,"marketCap":1623256016},{"date":"2022-10-28","current":-6.38779,"twenty":-16.25447,"median":-7.704859,"eighty":-5.495596,"marketCap":1514212864},{"date":"2022-11-04","current":-5.93824,"twenty":-16.191664,"median":-7.669515,"eighty":-5.50695,"marketCap":1407647965},{"date":"2022-11-11","current":-4.370461,"twenty":-16.164134,"median":-7.652802,"eighty":-5.468216,"marketCap":1129445090},{"date":"2022-11-18","current":-4.235391,"twenty":-16.131819,"median":-7.634387,"eighty":-5.449521,"marketCap":1094539502},{"date":"2022-11-25","current":-4.013492,"twenty":-16.117268,"median":-7.600529,"eighty":-5.3467,"marketCap":1037194608},{"date":"2022-12-02","current":-3.88807,"twenty":-16.102248,"median":-7.558277,"eighty":-5.287232,"marketCap":1004782276},{"date":"2022-12-09","current":-3.38156,"twenty":-16.041207,"median":-7.516892,"eighty":-5.259745,"marketCap":873886322},{"date":"2022-12-16","current":-3.116245,"twenty":-16.020651,"median":-7.489702,"eighty":-5.234588,"marketCap":805321775},{"date":"2022-12-23","current":-2.942584,"twenty":-16.001894,"median":-7.470459,"eighty":-5.20082,"marketCap":760443162},{"date":"2022-12-30","current":-3.347792,"twenty":-15.991931,"median":-7.407118,"eighty":-5.178447,"marketCap":865159925},{"date":"2023-01-06","current":-3.154836,"twenty":-15.985184,"median":-7.391436,"eighty":-5.132899,"marketCap":815294800},{"date":"2023-01-13","current":-3.116245,"twenty":-15.876323,"median":-7.35672,"eighty":-5.045571,"marketCap":805321775},{"date":"2023-01-20","current":-2.884697,"twenty":-15.769148,"median":-7.319501,"eighty":-5.004818,"marketCap":745483624},{"date":"2023-01-27","current":-3.222371,"twenty":-15.58994,"median":-7.255526,"eighty":-4.957491,"marketCap":832747594},{"date":"2023-02-03","current":-3.280258,"twenty":-15.495784,"median":-7.203252,"eighty":-4.852942,"marketCap":847707131},{"date":"2023-02-10","current":-2.759276,"twenty":-15.372215,"median":-7.16602,"eighty":-4.658733,"marketCap":713071293},{"date":"2023-02-17","current":-2.51808,"twenty":-15.281245,"median":-7.127136,"eighty":-4.40097,"marketCap":650739886},{"date":"2023-02-24","current":-2.054985,"twenty":-15.24139,"median":-7.072347,"eighty":-4.297137,"marketCap":531063585},{"date":"2023-03-03","current":-3.026095,"twenty":-15.184647,"median":-7.037219,"eighty":-4.234774,"marketCap":554132528},{"date":"2023-03-10","current":-2.712581,"twenty":-15.144685,"median":-7.009208,"eighty":-4.144702,"marketCap":496722401},{"date":"2023-03-17","current":-2.903416,"twenty":-15.067786,"median":-7.002092,"eighty":-4.0308,"marketCap":531667696},{"date":"2023-03-24","current":-2.739843,"twenty":-15.002478,"median":-6.947944,"eighty":-3.941641,"marketCap":501714586},{"date":"2023-03-31","current":-3.21693,"twenty":-14.979788,"median":-6.847795,"eighty":-3.877116,"marketCap":589077822},{"date":"2023-04-06","current":-3.503182,"twenty":-14.95508,"median":-6.791326,"eighty":-3.841772,"marketCap":641495764},{"date":"2023-04-14","current":-3.775804,"twenty":-14.928236,"median":-6.698816,"eighty":-3.793887,"marketCap":691417614},{"date":"2023-04-21","current":-3.053357,"twenty":-14.866404,"median":-6.650816,"eighty":-3.755799,"marketCap":559124713},{"date":"2023-04-28","current":-2.658057,"twenty":-14.849916,"median":-6.633253,"eighty":-3.642559,"marketCap":486738031},{"date":"2023-05-05","current":-3.298717,"twenty":-14.821751,"median":-6.575974,"eighty":-3.508635,"marketCap":604054377},{"date":"2023-05-12","current":-3.457401,"twenty":-14.671725,"median":-6.54314,"eighty":-3.473214,"marketCap":629015302},{"date":"2023-05-19","current":-3.457401,"twenty":-14.499848,"median":-6.38779,"eighty":-3.464474,"marketCap":629015302},{"date":"2023-05-26","current":-3.896436,"twenty":-14.407436,"median":-6.36768,"eighty":-3.473214,"marketCap":708890261},{"date":"2023-06-02","current":-4.568708,"twenty":-14.396483,"median":-6.357152,"eighty":-3.473214,"marketCap":831198792},{"date":"2023-06-09","current":-4.225712,"twenty":-14.3479,"median":-6.281438,"eighty":-3.503182,"marketCap":768796480},{"date":"2023-06-16","current":-5.29586,"twenty":-14.061441,"median":-6.257519,"eighty":-3.503182,"marketCap":963491693},{"date":"2023-06-23","current":-4.513829,"twenty":-14.001658,"median":-6.228162,"eighty":-3.524992,"marketCap":821214422},{"date":"2023-06-30","current":-4.294311,"twenty":-13.948149,"median":-6.173469,"eighty":-3.546802,"marketCap":781276943},{"date":"2023-07-07","current":-3.930735,"twenty":-13.84851,"median":-6.1421,"eighty":-3.566976,"marketCap":715130492},{"date":"2023-07-14","current":-4.294311,"twenty":-13.72267,"median":-6.113185,"eighty":-3.59924,"marketCap":781276943},{"date":"2023-07-21","current":-4.253152,"twenty":-13.554855,"median":-6.089817,"eighty":-3.631866,"marketCap":773788665},{"date":"2023-07-27","current":-4.253152,"twenty":-13.33676,"median":-6.029058,"eighty":-3.639493,"marketCap":773788665},{"date":"2023-08-03","current":-3.622039,"twenty":-13.065106,"median":-5.995102,"eighty":-3.636951,"marketCap":658968412},{"date":"2023-08-11","current":-2.767887,"twenty":-12.950357,"median":-5.958308,"eighty":-3.576245,"marketCap":579872363},{"date":"2023-08-18","current":-2.684012,"twenty":-12.835607,"median":-5.924847,"eighty":-3.497188,"marketCap":562300473},{"date":"2023-08-25","current":-2.67203,"twenty":-12.688071,"median":-5.837903,"eighty":-3.457401,"marketCap":559790203},{"date":"2023-09-01","current":-2.863745,"twenty":-12.385974,"median":-5.708238,"eighty":-3.438793,"marketCap":599954522},{"date":"2023-09-08","current":-2.34851,"twenty":-11.95976,"median":-5.599079,"eighty":-3.385905,"marketCap":492012914},{"date":"2023-09-15","current":-2.090893,"twenty":-11.683423,"median":-5.5243,"eighty":-3.342883,"marketCap":438042109},{"date":"2023-09-22","current":-1.773365,"twenty":-11.566331,"median":-5.496599,"eighty":-3.255097,"marketCap":371519955},{"date":"2023-09-29","current":-1.881205,"twenty":-11.446898,"median":-5.468216,"eighty":-3.219106,"marketCap":394112385},{"date":"2023-10-06","current":-1.785347,"twenty":-11.38601,"median":-5.454194,"eighty":-3.197376,"marketCap":374030225},{"date":"2023-10-13","current":-1.869223,"twenty":-11.287653,"median":-5.39488,"eighty":-3.168343,"marketCap":391602115},{"date":"2023-10-20","current":-1.893187,"twenty":-11.163535,"median":-5.332679,"eighty":-3.158301,"marketCap":396622655},{"date":"2023-10-27","current":-1.953098,"twenty":-11.1448,"median":-5.313106,"eighty":-3.154836,"marketCap":409174005},{"date":"2023-11-03","current":-2.396439,"twenty":-11.032392,"median":-5.288147,"eighty":-3.144199,"marketCap":502053994},{"date":"2023-11-10","current":-2.901609,"twenty":-10.969163,"median":-5.278444,"eighty":-3.116245,"marketCap":551593039},{"date":"2023-11-17","current":-2.47763,"twenty":-10.950428,"median":-5.259038,"eighty":-3.07552,"marketCap":470994970},{"date":"2023-11-24","current":-2.225892,"twenty":-10.948086,"median":-5.259038,"eighty":-3.034274,"marketCap":423139866},{"date":"2023-12-01","current":-2.292139,"twenty":-10.919984,"median":-5.220226,"eighty":-2.985202,"marketCap":435733314},{"date":"2023-12-08","current":-2.570375,"twenty":-10.859097,"median":-5.20082,"eighty":-2.966092,"marketCap":488625797},{"date":"2023-12-15","current":-2.67637,"twenty":-10.781816,"median":-5.191971,"eighty":-2.932936,"marketCap":508775315},{"date":"2023-12-22","current":-2.649872,"twenty":-10.622571,"median":-5.162008,"eighty":-2.925226,"marketCap":503737936},{"date":"2023-12-29","current":-2.795615,"twenty":-10.526556,"median":-5.142602,"eighty":-2.903531,"marketCap":531443522},{"date":"2024-01-05","current":-2.636622,"twenty":-10.491428,"median":-5.132899,"eighty":-2.892415,"marketCap":501219246},{"date":"2024-01-12","current":-2.914859,"twenty":-10.423515,"median":-5.074619,"eighty":-2.876069,"marketCap":554111729},{"date":"2024-01-19","current":-2.610123,"twenty":-10.297056,"median":-5.040719,"eighty":-2.870527,"marketCap":496181866},{"date":"2024-01-26","current":-2.769116,"twenty":-9.948122,"median":-4.987353,"eighty":-2.82681,"marketCap":526406143},{"date":"2024-02-02","current":-2.451131,"twenty":-9.674127,"median":-4.970553,"eighty":-2.813035,"marketCap":465957590},{"date":"2024-02-09","current":-2.26564,"twenty":-9.360321,"median":-4.907373,"eighty":-2.806332,"marketCap":430695935},{"date":"2024-02-16","current":-2.517378,"twenty":-9.114428,"median":-4.849986,"eighty":-2.790315,"marketCap":478551039},{"date":"2024-02-23","current":-3.232843,"twenty":-9.044173,"median":-4.776239,"eighty":-2.787665,"marketCap":614560281},{"date":"2024-03-01","current":-3.162234,"twenty":-9.011387,"median":-4.733346,"eighty":-2.795615,"marketCap":741961228},{"date":"2024-03-08","current":-2.729051,"twenty":-8.93879,"median":-4.699047,"eighty":-2.787665,"marketCap":640322703},{"date":"2024-03-15","current":-2.393334,"twenty":-8.826382,"median":-4.580215,"eighty":-2.779437,"marketCap":561552847},{"date":"2024-03-22","current":-2.209232,"twenty":-8.791255,"median":-4.524152,"eighty":-2.767887,"marketCap":518356474},{"date":"2024-03-28","current":-2.209232,"twenty":-8.749102,"median":-4.472669,"eighty":-2.760842,"marketCap":518356474},{"date":"2024-04-05","current":-2.26338,"twenty":-8.661036,"median":-4.437996,"eighty":-2.746312,"marketCap":531061289},{"date":"2024-04-12","current":-2.880665,"twenty":-8.612285,"median":-4.40407,"eighty":-2.740398,"marketCap":675896187},{"date":"2024-04-19","current":-2.523289,"twenty":-8.473521,"median":-4.37663,"eighty":-2.729051,"marketCap":592044404},{"date":"2024-04-26","current":-2.390385,"twenty":-8.435978,"median":-4.373545,"eighty":-2.713288,"marketCap":560860924},{"date":"2024-05-03","current":-2.607693,"twenty":-8.343298,"median":-4.308031,"eighty":-2.687454,"marketCap":611848281},{"date":"2024-05-10","current":-2.992192,"twenty":-8.3219,"median":-4.294311,"eighty":-2.687454,"marketCap":683237114},{"date":"2024-05-17","current":-3.103841,"twenty":-8.319809,"median":-4.254687,"eighty":-2.687454,"marketCap":708731037},{"date":"2024-05-24","current":-3.025687,"twenty":-8.307263,"median":-4.253152,"eighty":-2.697369,"marketCap":690885291},{"date":"2024-05-31","current":-2.969862,"twenty":-8.290536,"median":-4.253152,"eighty":-2.702869,"marketCap":678138330},{"date":"2024-06-07","current":-2.768894,"twenty":-8.254974,"median":-4.239432,"eighty":-2.702869,"marketCap":632249270},{"date":"2024-06-14","current":-2.891708,"twenty":-8.249968,"median":-4.234362,"eighty":-2.702869,"marketCap":660292584},{"date":"2024-06-21","current":-2.322298,"twenty":-8.16114,"median":-4.225712,"eighty":-2.684796,"marketCap":530273581},{"date":"2024-06-28","current":-1.540756,"twenty":-8.102755,"median":-4.225015,"eighty":-2.684012,"marketCap":351816126},{"date":"2024-07-05","current":-1.685899,"twenty":-8.085705,"median":-4.184553,"eighty":-2.678934,"marketCap":384958225},{"date":"2024-07-12","current":-1.898032,"twenty":-8.051656,"median":-4.129469,"eighty":-2.657094,"marketCap":433396677},{"date":"2024-07-15","current":-1.909197,"twenty":-8.044209,"median":-4.129265,"eighty":-2.653244,"marketCap":435946069},{"date":"2024-08-02","current":-1.674734,"twenty":-8.037183,"median":-4.122609,"eighty":-2.651573,"marketCap":382408833},{"date":"2024-08-09","current":-1.826341,"twenty":-8.006826,"median":-4.102234,"eighty":-2.638911,"marketCap":384004669},{"date":"2024-08-16","current":-1.528039,"twenty":-7.995377,"median":-4.066555,"eighty":-2.636083,"marketCap":321283906},{"date":"2024-08-23","current":-1.765463,"twenty":-7.98391,"median":-4.033634,"eighty":-2.631614,"marketCap":371204513},{"date":"2024-08-30","current":-1.777639,"twenty":-7.976897,"median":-4.016703,"eighty":-2.61181,"marketCap":373764544},{"date":"2024-09-06","current":-1.558478,"twenty":-7.976897,"median":-3.997437,"eighty":-2.600136,"marketCap":327683984},{"date":"2024-09-13","current":-1.400195,"twenty":-7.950535,"median":-3.965035,"eighty":-2.577437,"marketCap":294403579},{"date":"2024-09-20","current":-1.899395,"twenty":-7.950535,"median":-3.965035,"eighty":-2.570375,"marketCap":399364856},{"date":"2024-09-27","current":-1.850692,"twenty":-7.950535,"median":-3.930735,"eighty":-2.557126,"marketCap":389124731},{"date":"2024-10-04","current":-1.448897,"twenty":-7.935078,"median":-3.892473,"eighty":-2.543877,"marketCap":304643704},{"date":"2024-10-11","current":-1.327141,"twenty":-7.903714,"median":-3.88807,"eighty":-2.530627,"marketCap":279043393},{"date":"2024-10-18","current":-1.436722,"twenty":-7.89199,"median":-3.841772,"eighty":-2.517378,"marketCap":302083673},{"date":"2024-10-25","current":-1.327141,"twenty":-7.88028,"median":-3.830328,"eighty":-2.499039,"marketCap":279043393},{"date":"2024-10-31","current":-1.045032,"twenty":-7.865572,"median":-3.823077,"eighty":-2.47498,"marketCap":219727471},{"date":"2024-11-08","current":-1.531082,"twenty":-7.853532,"median":-3.797329,"eighty":-2.424262,"marketCap":312323797},{"date":"2024-11-15","current":-1.505683,"twenty":-7.846411,"median":-3.786677,"eighty":-2.411954,"marketCap":307142675},{"date":"2024-11-22","current":-1.254644,"twenty":-7.841819,"median":-3.775936,"eighty":-2.392744,"marketCap":255933614},{"date":"2024-11-29","current":-1.293655,"twenty":-7.809622,"median":-3.759997,"eighty":-2.378477,"marketCap":263891402},{"date":"2024-12-06","current":-1.259298,"twenty":-7.769895,"median":-3.714409,"eighty":-2.359862,"marketCap":256882964},{"date":"2024-12-13","current":-1.040564,"twenty":-7.753827,"median":-3.659012,"eighty":-2.350461,"marketCap":212263510},{"date":"2024-12-20","current":-0.877402,"twenty":-7.748728,"median":-3.626782,"eighty":-2.335862,"marketCap":178980413},{"date":"2024-12-27","current":-0.889311,"twenty":-7.730167,"median":-3.608319,"eighty":-2.323428,"marketCap":181409632},{"date":"2025-01-03","current":-0.882877,"twenty":-7.704989,"median":-3.557707,"eighty":-2.2786,"marketCap":180097296},{"date":"2025-01-10","current":-0.933392,"twenty":-7.704643,"median":-3.503182,"eighty":-2.26338,"marketCap":190401751},{"date":"2025-01-17","current":-0.80048,"twenty":-7.694621,"median":-3.473214,"eighty":-2.228646,"marketCap":163289149},{"date":"2025-01-24","current":-0.836716,"twenty":-7.674536,"median":-3.466811,"eighty":-2.211961,"marketCap":170680839},{"date":"2025-01-31","current":-0.835284,"twenty":-7.664509,"median":-3.457401,"eighty":-2.190367,"marketCap":170388677},{"date":"2025-02-07","current":-0.846455,"twenty":-7.663257,"median":-3.446877,"eighty":-2.138425,"marketCap":172667538},{"date":"2025-02-14","current":-0.833565,"twenty":-7.64653,"median":-3.402521,"eighty":-2.079975,"marketCap":170038083},{"date":"2025-02-21","current":-0.94528,"twenty":-7.642348,"median":-3.38156,"eighty":-2.054451,"marketCap":192826692},{"date":"2025-02-28","current":-1.020902,"twenty":-7.637571,"median":-3.343701,"eighty":-1.975864,"marketCap":208252828},{"date":"2025-03-07","current":-1.040381,"twenty":-7.627362,"median":-3.298717,"eighty":-1.933206,"marketCap":212226226},{"date":"2025-03-14","current":-0.521867,"twenty":-7.609389,"median":-3.265577,"eighty":-1.89885,"marketCap":178997262},{"date":"2025-03-21","current":-0.459033,"twenty":-7.587984,"median":-3.241666,"eighty":-1.893187,"marketCap":157445555},{"date":"2025-03-28","current":-0.510936,"twenty":-7.570327,"median":-3.226697,"eighty":-1.876412,"marketCap":175247856},{"date":"2025-04-04","current":-0.400244,"twenty":-7.557107,"median":-3.21693,"eighty":-1.854621,"marketCap":137281423},{"date":"2025-04-11","current":-0.357121,"twenty":-7.549923,"median":-3.198363,"eighty":-1.833647,"marketCap":122490457},{"date":"2025-04-17","current":-0.377865,"twenty":-7.53571,"median":-3.1819,"eighty":-1.804679,"marketCap":129605473},{"date":"2025-04-25","current":-0.401966,"twenty":-7.516892,"median":-3.166597,"eighty":-1.777639,"marketCap":137871881},{"date":"2025-05-02","current":-0.404697,"twenty":-7.507686,"median":-3.164484,"eighty":-1.775075,"marketCap":138808651},{"date":"2025-05-09","current":-0.368533,"twenty":-7.490537,"median":-3.162234,"eighty":-1.765463,"marketCap":126404474},{"date":"2025-05-16","current":-0.354647,"twenty":-7.4795,"median":-3.154836,"eighty":-1.754194,"marketCap":118637096},{"date":"2025-05-23","current":-0.372922,"twenty":-7.470459,"median":-3.154836,"eighty":-1.730229,"marketCap":124750584},{"date":"2025-05-30","current":-0.355548,"twenty":-7.461092,"median":-3.125893,"eighty":-1.710392,"marketCap":118938486},{"date":"2025-06-06","current":-0.507293,"twenty":-7.420321,"median":-3.116245,"eighty":-1.685899,"marketCap":169700573},{"date":"2025-06-13","current":-0.431155,"twenty":-7.403982,"median":-3.113599,"eighty":-1.670898,"marketCap":144230679},{"date":"2025-06-20","current":-0.424072,"twenty":-7.391436,"median":-3.092676,"eighty":-1.665525,"marketCap":141861387},{"date":"2025-06-27","current":-0.403709,"twenty":-7.391436,"median":-3.084406,"eighty":-1.652405,"marketCap":135049671},{"date":"2025-07-03","current":-0.428941,"twenty":-7.389083,"median":-3.074,"eighty":-1.61891,"marketCap":143490275},{"date":"2025-07-11","current":-0.432483,"twenty":-7.365757,"median":-3.059181,"eighty":-1.558478,"marketCap":144674922},{"date":"2025-07-18","current":-0.421416,"twenty":-7.354708,"median":-3.044181,"eighty":-1.530473,"marketCap":140972902},{"date":"2025-07-25","current":-0.460813,"twenty":-7.344,"median":-3.026095,"eighty":-1.517452,"marketCap":154152091},{"date":"2025-08-01","current":-0.523591,"twenty":-7.306207,"median":-3.009843,"eighty":-1.505683,"marketCap":175152551}],"updateTime":1754131861355}}}